跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
施 怡賢
助理教授
,
皮膚學科
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0003-2095-7064
電子郵件
yh.shih
tmu.edu
tw
h-index
201
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2024
每年研究成果
概覽
指紋
網路
專案
(4)
研究成果
(29)
類似的個人檔案
(6)
指紋
查看啟用 Yi-Hsien Shih 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Rhinophyma
100%
Acneiform Eruption
88%
Papulopustular
57%
Acne Vulgaris
56%
Dermatitis
54%
Adjuvant Therapy
50%
Nodular Melanoma
50%
Pediatrics
50%
Propionibacterium acnes
50%
Malassezia Folliculitis
50%
Transcriptomics
50%
Interleukin-1
50%
Deoxyribonuclease I
50%
Nevus Sebaceous
50%
Durvalumab
50%
Drug Eruption
50%
Nicotinamide
50%
Proteomics
50%
Tetracycline
50%
Drug
50%
Retrospective Study
50%
Phototherapy
50%
Topical Treatment
50%
Contact Dermatitis
50%
Gram Staining
50%
Chromosome Segregation
50%
Immune Dysregulation
50%
Neuroinflammation
50%
Immune Checkpoint Inhibitor
37%
Immunosuppressant
37%
Side Effect
25%
Programmed Death 1 Ligand 1
25%
Antibiotics
18%
Antiinfective Agent
18%
Allergen
18%
Antibiotic Resistance
18%
Antiinflammatory Agent
12%
Sebum
12%
Adverse Event
12%
Malignant Neoplasm
12%
Patch Test
12%
Exanthem
12%
Sunscreen
12%
Monoclonal Antibody
12%
Methotrexate
12%
Systemic Immune-Inflammation Index
11%
Folliculitis
8%
Tumor Necrosis Factor
8%
Sensitivity and Specificity
8%
Signal Transduction
8%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Mitogen Activated Protein Kinase 3
80%
Vemurafenib
50%
Drug
50%
Microphthalmia Associated Transcription Factor
50%
Link Protein
50%
Retrospective Study
50%
Deoxyribonuclease I
50%
Propionibacterium acnes
50%
Binding Protein
50%
Drug Eruption
50%
Lapatinib
50%
Colorectal Tumor
50%
Sorafenib
50%
Durvalumab
50%
Tetracycline
50%
Sunitinib
50%
Nicotinamide
50%
Contact Dermatitis
50%
Acne
38%
Immunosuppressive Agent
37%
Immune Checkpoint Inhibitor
37%
Neoplasm
30%
Programmed Death 1 Ligand 1
25%
Malignant Neoplasm
22%
Allergen
18%
Drug Resistance
17%
Isobutylmethylxanthine
14%
Adverse Event
12%
Methotrexate
12%
Rash
12%
Monoclonal Antibody
12%
Acne Vulgaris
11%
Mouse
10%
Growth Factor Receptor
10%
Tumor Regression
10%
Western Blot
10%
Colorectal Cancer
10%
Tumor Resistance
10%
Cause of Death
10%
Colon Cancer
10%
Protein Kinases
7%
Drug Delivery System
7%
Short Hairpin RNA
7%
Tyrosinase
7%
Antiinfective Agent
6%
Clinical Feature
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Antibiotic Agent
6%
Contact Allergy
6%
Immunology and Microbiology
Biofilm
100%
Interleukin-1
50%
Transcriptomics
50%
Propionibacterium acnes
50%
Explant
50%
Virus Quantification
50%
Secretion (Process)
50%
Streptococcus mutans
50%
Hepatitis B Virus
50%
Real Time Polymerase Chain Reaction
50%
Virus Detection
50%
Rosaceae
50%
Endocarditis
50%
Blood Cell Count
50%
Lymphocyte
50%
Virus Mutant
25%
Polymerase Chain Reaction
25%
Wild Type
22%
Surface Property
20%
Neutrophil
19%
Platelet
19%
Immunity
14%
Melting Temperature
12%
Viral Load
12%
Hepatitis B
12%
Heart Valve
10%
Alpha Hemolytic Streptococcus
10%
Tumor Necrosis Factor
8%
Signal Transduction
8%
Antimicrobial Resistance
6%
Surface Plasmon Resonance
6%
Molecular Docking
6%
Enzyme Kinetics
6%
